MIRM
Mirum Pharmaceuticals Inc
Price:  
44.28 
USD
Volume:  
392,599.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MIRM WACC - Weighted Average Cost of Capital

The WACC of Mirum Pharmaceuticals Inc (MIRM) is 8.5%.

The Cost of Equity of Mirum Pharmaceuticals Inc (MIRM) is 8.75%.
The Cost of Debt of Mirum Pharmaceuticals Inc (MIRM) is 7.00%.

Range Selected
Cost of equity 7.40% - 10.10% 8.75%
Tax rate 0.40% - 0.80% 0.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 7.3% - 9.7% 8.5%
WACC

MIRM WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.77 0.93
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.40% 10.10%
Tax rate 0.40% 0.80%
Debt/Equity ratio 0.14 0.14
Cost of debt 7.00% 7.00%
After-tax WACC 7.3% 9.7%
Selected WACC 8.5%